Previous work has shown that the transfer of B6-
me v /me v bone marrow into irradiated syngeneic wild-type hosts can transfer the autoimmune disease 2 to 3 weeks after transplantation,
12 demonstrating that the immunologic dysfunction caused by the
me v /me v mutation is determined at the level of bone marrow progenitor cells. To determine whether the retinal degeneration of
me v /me v mice is also determined at the level of bone marrow progenitor cells, bone marrow from B6-
me v /me v mice was injected intravenously into irradiated syngeneic wild-type hosts. Histopathologic examination of recipients of B6-
me v /me v marrow, 5 to 7 weeks after transplantation, revealed acidophilic macrophage pneumonia, the hallmark lesion of
me v /me v mice, but no retinal degeneration
(Fig. 6C 6D) . Because recipients of B6-
me v /me v bone marrow do not live beyond 7 weeks after transplantation, it is possible that the retinal degeneration develops more slowly and is not morphologically evident at the time of death. Bone marrow transplantation experiments were repeated in BALB/cBy mice.
me v /me v mice on the BALB/cBy background show a more severe and earlier onset of retinal degeneration, with complete loss of photoreceptors by 5 weeks of age (Lyons BL, unpublished data, 2002). As in recipients of B6-
me v /me v marrow, retinal degeneration was not evident in recipients of BALB/cByJ-
me v /me v bone marrow (data not shown). These results suggest that there is a retina-specific defect in
me v /me v mice and retinal degeneration is not determined at the level of bone marrow–derived progenitor cells.